APA (7th ed.) Citation

A, S., EM, B., G, J., J, K., NM, H., D, W., & RV, O. (2026). Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach. Diabetes, obesity & metabolism, 28(6), 4926. https://doi.org/10.1111/dom.70678

Chicago Style (17th ed.) Citation

A, Strathe, Bomberg EM, Jensch G, Kildegaard J, Harder-Lauridsen NM, Weghuber D, and Overgaard RV. "Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach." Diabetes, Obesity & Metabolism 28, no. 6 (2026): 4926. https://doi.org/10.1111/dom.70678.

MLA (9th ed.) Citation

A, Strathe, et al. "Efficacy, Safety and Pharmacokinetics of Semaglutide 1.7 mg for Obesity Treatment in Adolescents: A Model-Informed Drug Development Approach." Diabetes, Obesity & Metabolism, vol. 28, no. 6, 2026, p. 4926, https://doi.org/10.1111/dom.70678.